Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kenvue Inc (KVUE)

Kenvue Inc (KVUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Kenvue Stock: Is KVUE Underperforming the Consumer Defensive Sector?

With a market cap of $32.5 billion, Kenvue Inc. (KVUE) is a global consumer health company serving markets across the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three main segments: Self Care, Skin Health and Beauty, and Essential Health. 

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Kenvue fits this criterion perfectly. The company’s portfolio includes well-known brands such as Tylenol, Neutrogena, Listerine, and Johnson’s.

Fundamentals

See More
  • Market Capitalization, $K 32,549,476
  • Shares Outstanding, K 1,915,802
  • Annual Sales, $ 15,455 M
  • Annual Income, $ 1,030 M
  • EBIT $ 2,362 M
  • EBITDA $ 2,984 M
  • 60-Month Beta 0.60
  • Price/Sales 2.10
  • Price/Cash Flow 11.53
  • Price/Book 3.06

Options Overview Details

View History
  • Implied Volatility 38.42% (-2.63%)
  • Historical Volatility 39.89%
  • IV Percentile 65%
  • IV Rank 29.61%
  • IV High 92.41% on 12/03/25
  • IV Low 15.71% on 05/28/25
  • Expected Move (DTE 7) 0.46 (2.71%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 13,678
  • Volume Avg (30-Day) 60,387
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 1,285,433
  • Open Int (30-Day) 1,919,236
  • Expected Range 16.47 to 17.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.22
  • Number of Estimates 3
  • High Estimate 0.23
  • Low Estimate 0.21
  • Prior Year 0.26
  • Growth Rate Est. (year over year) -15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.94 +6.21%
on 11/17/25
17.55 -3.53%
on 12/01/25
+0.70 (+4.31%)
since 11/05/25
3-Month
14.02 +20.76%
on 10/30/25
19.42 -12.82%
on 09/12/25
-1.69 (-9.08%)
since 09/05/25
52-Week
14.02 +20.76%
on 10/30/25
25.17 -32.74%
on 05/08/25
-6.20 (-26.81%)
since 12/05/24

Most Recent Stories

More News
Kenvue Stock: Is KVUE Underperforming the Consumer Defensive Sector?

As Kenvue has performed weaker than the consumer defensive sector over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

PG : 143.45 (-1.31%)
KVUE : 16.93 (-0.35%)
XLP : 78.46 (+0.01%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-KVUE, KMB, SM, and CDE

NEW YORK , Nov. 21, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

KMB : 102.96 (-1.89%)
CDE : 15.86 (-1.49%)
KVUE : 16.93 (-0.35%)
SM : 20.12 (-0.59%)
3 Smart Defensive Stocks for an Uneasy Market

Recession risks persist despite record market highs. Here are three defensive stocks—including PG, JNJ, and the DIA ETF—that can help protect your portfolio

JPM : 315.04 (-0.34%)
PG : 143.45 (-1.31%)
JNJ : 201.93 (-0.27%)
KVUE : 16.93 (-0.35%)
SPY : 685.69 (+0.19%)
DIA : 480.03 (+0.20%)
Halper Sadeh LLC Encourages JAMF, SNDA, KVUE, SM Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

JAMF : 12.97 (+0.08%)
KVUE : 16.93 (-0.35%)
SM : 20.12 (-0.59%)
SNDA : 30.79 (+1.62%)
Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction

Kimberly-Clark's acquisition of Kenvue creates a global leader in health and wellness, positioning its iconic brands for accelerated long-term growth.

KMB : 102.96 (-1.89%)
KVUE : 16.93 (-0.35%)
Losses for Big Tech pull Wall Street lower

Stocks fell on Wall Street, pulled down by losses in the same big tech companies that have been the main drivers of the market's rally so far this year

KMB : 102.96 (-1.89%)
NVDA : 182.41 (-0.53%)
MTSR : 70.50 (-0.35%)
$SPX : 6,870.40 (+0.19%)
EXPE : 263.43 (+1.95%)
$IUXX : 25,692.05 (+0.43%)
PFE : 26.03 (+1.28%)
MCD : 311.23 (+0.87%)
MSFT : 483.16 (+0.48%)
IREN : 44.71 (-3.75%)
YUM : 144.96 (-0.62%)
TSLA : 455.00 (+0.10%)
Stock Index Futures Plunge on Valuation Concerns

December S&P 500 E-Mini futures (ESZ25) are down -1.01%, and December Nasdaq 100 E-Mini futures (NQZ25) are down -1.31% this morning as quarterly results from AI bellwether Palantir failed to impress investors...

NVDA : 182.41 (-0.53%)
ANET : 128.59 (+0.03%)
SPOT : 564.93 (+0.71%)
SRPT : 22.26 (-2.45%)
GEBN.Z.EB : 621.400 (+0.47%)
MU : 237.22 (+4.66%)
FN : 478.45 (+1.41%)
NQZ25 : 25,732.00s (+0.43%)
AMGN : 329.89 (-3.02%)
PFE : 26.03 (+1.28%)
EDEN.P.DX : 18.910 (+1.83%)
SHOP : 161.08 (-0.76%)
AI darlings prop up Wall Street as most other stocks fall

Nvidia and other AI superstar stocks propped up Wall Street

META : 673.42 (+1.80%)
NVDA : 182.41 (-0.53%)
KMB : 102.96 (-1.89%)
AAPL : 278.78 (-0.68%)
SPOT : 564.93 (+0.71%)
$SPX : 6,870.40 (+0.19%)
$IUXX : 25,692.05 (+0.43%)
DASH : 225.00 (+1.72%)
MCD : 311.23 (+0.87%)
MSFT : 483.16 (+0.48%)
IREN : 44.71 (-3.75%)
BYND : 1.2200 (-1.61%)
Kenvue Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kenvue Inc. - KVUE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Kenvue Inc....

KMB : 102.96 (-1.89%)
KVUE : 16.93 (-0.35%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kenvue Inc.

NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kenvue Inc. (NYSE: KVUE) and its board of directors concerning the proposed acquisition...

KMB : 102.96 (-1.89%)
KVUE : 16.93 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.

See More

Key Turning Points

3rd Resistance Point 17.33
2nd Resistance Point 17.21
1st Resistance Point 17.07
Last Price 16.93
1st Support Level 16.81
2nd Support Level 16.69
3rd Support Level 16.55

See More

52-Week High 25.17
Fibonacci 61.8% 20.91
Fibonacci 50% 19.60
Fibonacci 38.2% 18.28
Last Price 16.93
52-Week Low 14.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar